Top Therapeutics Companies in Europe
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top Therapeutics Companies in Europe
Therapeutics News
Advancing Nutritional Recovery through Local Therapy
Thursday, August 13, 2026
Delayed return to eating after major surgery can turn a planned recovery window into extended hospitalisation. Gastrointestinal dysfunction adds discomfort, delays bowel function, increases readmission risk and keeps scarce beds occupied. Failure to restart oral intake can also complicate discharge planning and prompt avoidable nutrition support. Clinical-stage therapies aimed at nutritional recovery must therefore do more than stimulate appetite in theory. They need a defined biological target and trial endpoints that reflect what matters after surgery, including food intake and the return of gastrointestinal function. Asset selection becomes difficult when one mechanism appear
Tune Therapeutics Adds New Chief Scientific Officer and General Counsel
Wednesday, July 10, 2024
Tune Therapeutics adds Chief Scientific Officer Derek Jantz, Ph.D., and General Counsel, Zachary Hale, J.D., to enhance precision genetic-tuning treatments. FREMONT, CA: "Dr. Jantz's experience in taking novel modalities from inception to preclinical and clinical-stage therapies makes him an ideal addition to our team. His knowledge in this area is unsurpassed, and we're eager to incorporate his scientific expertise as we advance our TEMPO genetic tuning platform," said Matt Kane, CEO of
Europe's Ethical Approach to Longevity Therapeutics
Friday, June 07, 2024
European researchers are revolutionising longevity therapeutics by focusing on cellular senescence, telomere maintenance, sirtuins, gut microbiome manipulation, and mTOR signalling pathways. This work requires collaboration, open dialogues, and citizen engagement. FREMONT, CA: The quest for extended lifespans has fascinated humanity for millennia. This ancient aspiration is merging with science in Europe, driving a revolution in longevity therapeutics. European researchers are leading breakthroughs in understanding the ageing process. One primary focus is cellular senescence, where cells stop dividing and contribute to tissue dysf
Advances and Accessibility in European Mental Health Therapeutics
Friday, June 07, 2024
Europe is enhancing mental health therapeutics with innovative treatments, ketamine-based drugs, evidence-based psychotherapy, and digital therapeutics, requiring collaboration among stakeholders for comprehensive, accessible mental health ecosystems. FREMONT, CA: Europe has long grappled with pervasive mental health challenges, including widespread instances of anxiety, depression, and post-traumatic stress disorder (PTSD). However, the mental health therapeutics field is undergoing a significant transformation, characterised by introduction of innovative treatments and an increased emphasis on accessibility. The pharmaceutical i
Biotherapeutics To Transform Cancer Treatment With Innovative Approaches
Friday, June 30, 2023
Opting for biotherapeutics enables early diagnosis and offers tailored treatments for patients, especially in treating cancer. FREMONT, CA: The field of biotherapeutics research is experiencing considerable growth within the pharmaceutical industry, currently representing nearly half of all new drug approvals. Unlike traditional small-molecule medications synthesised chemically, biotherapeutic medicines are produced using living systems. Serving as a crucial element of modern medicine, biotherapeutics play a pivotal role in the tr
Europe, Emerging as the Frontier in Biotherapeutics
Friday, June 30, 2023
A personalised medical approach and targeted therapies are critically transforming the European infrastructure in biotherapeutics for a robust and collaborative effort, driving potential patient outcomes and cost-effectiveness in the arena. FREMONT, CA: Biotherapeutics has unquestionably become a game-changing force in the field of life sciences, presenting groundbreaking and precise remedies for a diverse array of illnesses, spanning from the ordinary cold to persistent conditions. Europe consistently takes a leading position in this transformative journey, boasting a resilient infrastructure and promising research capabilities. Embracing
